Art
J-GLOBAL ID:201202249049470156   Reference number:12A0261917

選択的バソプレシンV2受容体拮抗薬はどう使う

Author (1):
Material:
Volume: 71  Issue:Page: 69-75  Publication year: Jan. 28, 2012 
JST Material Number: Y0038A  ISSN: 1884-2909  Document type: Article
Article type: 解説  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A0261917&from=J-GLOBAL&jstjournalNo=Y0038A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Drugs acting on circulatory system in general 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (10):
  • 1) Nohria A, Tsang SW, Fang JC, et al. Clinical assess-ment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003 ; 41 : 1797.
  • 2) Gheorghiade M, Gattis WA, O'Connor CM, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure : a randomized controlled trial. JAMA 2004 ; 291(16) : 1963.
  • 3) Gheorghiade M, Konstam MA, Burnett JC Jr, et al. Short-term clinical effects of tolvaptan, an oral va-sopressin antagonist, in patients hospitalized for heart failure : the EVEREST Clinical Status Trials. JAMA 2007 ; 297 (12) : 1332.
  • 4) Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure : the EVEREST Outcome Trial. JAMA 2007 ; 297 (12) : 1319.
  • 5) Udelson JE, Orlandi C, Ouyang J, et al. Acute he-modynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction : an international, multicenter, randomized, placebo-controlled trial. J Am Coll Cardiol 2008 ; 52 (19) : 1540.
more...
Terms in the title (1):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page